Phase 4 Depression and Anxiety Trial, Recruiting NCT05895383 Sponsor: Beth Israel Deaconess Medical Center Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Recruiting

NCT05895383
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are scheduled to have a vasectomy
  • People aged between 21 and 85 years
  • People who are considered suitable to breathe a nitrous oxide and oxygen gas mixture (confirm with trial site)
  • People who have access to an email address and a computer

Who may not be able to join:

  • People who have facial hair around the mouth area that would prevent a gas mask from fitting properly
  • People with a cognitive impairment that would make it difficult to answer survey questions
  • People who plan to use benzodiazepines (sedatives) or opioids (strong painkillers) on an as-needed basis specifically for their vasectomy
  • People who have had inner ear, weight-loss (bariatric), or eye surgery within the last 2 weeks
  • People who currently have emphysematous blebs (damaged air pockets in the lungs) (confirm with trial site)
  • People with a severe Vitamin B12 deficiency
  • People who have received the chemotherapy drug bleomycin within the past year
  • People who have had a heart attack within the past year
  • People who have had a stroke within the past year
  • People with Class III or higher heart failure (a more advanced stage of heart failure) (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Heidi Rayala, MD, PhD, Beth Israel Deaconess Medical Center

Phone: 617-667-3739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
24 May 2023
Est. completion
30 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Procedural pain assessed by the Visual Analog Scale for Pain (VAS-P)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov